Key statistics
On Tuesday, OS Therapies Inc (OSTX:ASQ) closed at 2.63, 4.78% above its 52-week low of 2.51, set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.70 |
---|---|
High | 2.87 |
Low | 2.60 |
Bid | 2.62 |
Offer | 2.87 |
Previous close | 2.68 |
Average volume | 14.24k |
---|---|
Shares outstanding | 20.05m |
Free float | 15.07m |
P/E (TTM) | -- |
Market cap | 53.73m USD |
EPS (TTM) | -0.3011 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 23:30 GMT.
More ▼
- OS Therapies to Present at The Spartan Capital Investor Conference
- Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30
- OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
- OS Therapies to Present at the LD Micro Main Event XVII
- OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit
- OS Therapies Announces Development of Two Novel Tunable Antibody Drug Conjugate (tADC)-Based Therapeutic Candidates
- OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference
- OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Receives Last Treatment Dose
- OS Therapies Appoints Borys Shor, PhD to ADC Advisory Board
More ▼